These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11535935)

  • 1. Changes in insulin-like growth factor I, 17-b-estradiol, and progesterone in postmenopausal women with benign and malignant ovarian tumours.
    Waksmański B; Dudkiewicz J; Kowalski T
    Med Sci Monit; 2001; 7(5):919-23. PubMed ID: 11535935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of estradiol and progesterone differs in serum and tissue of benign and malignant ovarian tumors.
    Lindgren PR; Bäckström T; Cajander S; Damber MG; Mählck CG; Zhu D; Olofsson JI
    Int J Oncol; 2002 Sep; 21(3):583-9. PubMed ID: 12168103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer.
    Karasik A; Menczer J; Pariente C; Kanety H
    J Clin Endocrinol Metab; 1994 Feb; 78(2):271-6. PubMed ID: 7508947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor (IGF)-I and IGF-II serum concentrations in patients with benign and malignant breast lesions: free IGF-II is correlated with breast cancer size.
    Singer CF; Mogg M; Koestler W; Pacher M; Marton E; Kubista E; Schreiber M
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4003-9. PubMed ID: 15217931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone and estradiol stimulate release of epidermal growth factor/transforming growth factor alpha by ovarian tumours in vitro.
    Ridderheim M; Stendahl U; Bäckström T
    Anticancer Res; 1994; 14(6B):2763-8. PubMed ID: 7872715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Bezemer ID; Rinaldi S; Dossus L; Gils CH; Peeters PH; Noord PA; Bueno-de-Mesquita HB; Johnsen SP; Overvad K; Olsen A; Tjønneland A; Boeing H; Lahmann PH; Linseisen J; Nagel G; Allen N; Roddam A; Bingham S; Khaw KT; Kesse E; Téhard B; Clavel-Chapelon F; Agudo A; Ardanaz E; Quiros JR; Amiano P; Martínez-Garcia C; Tormo MJ; Pala V; Panico S; Vineis P; Palli D; Tumino R; Trichopoulou A; Baibas N; Zilis D; Hémon B; Norat T; Riboli E; Kaaks R
    Cancer Causes Control; 2005 Jun; 16(5):561-72. PubMed ID: 15986111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum thrombopoietin levels are higher in patients with ovarian cancer than with benign cysts.
    Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):67-70. PubMed ID: 16359773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women.
    Lebrun CE; van der Schouw YT; de Jong FH; Pols HA; Grobbee DE; Lamberts SW
    Maturitas; 2006 Aug; 55(1):82-92. PubMed ID: 16497451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma hormones, muscle mass and strength in resistance-trained postmenopausal women.
    Orsatti FL; Nahas EA; Maesta N; Nahas-Neto J; Burini RC
    Maturitas; 2008 Apr; 59(4):394-404. PubMed ID: 18499368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
    Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Placental protein 12 (PP 12) in cyst and peritoneal fluids and serum samples of patients with ovarian cysts and cystic ovarian tumors].
    Strache RR; Göcze PM; Szábo DG; Büttner HH; Briese V; Kunze M; Csaba IF; Röpcke G
    Zentralbl Gynakol; 1989; 111(11):749-54. PubMed ID: 2781888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid production in different parts of malignant and benign ovarian tumors in vitro.
    Ridderheim M; Mählck CG; Selstam G; Stendahl U; Bäckström T
    Cancer Res; 1993 May; 53(10 Suppl):2309-12. PubMed ID: 8485717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.